Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Protagonist Therapeutics at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Protagonist Therapeutics brings 2 presentations to Discovery on Target 2026 in Boston. Its program centres on autoimmune targets, including an oral peptide IL-17 antagonist and the hurdles of small-molecule discovery for these diseases.

OrganizationDiscovery on Target 2026 Attendance
protagonist-inc.com
Biotech
Develops peptide drugs, including oral IL-23 receptor and IL-17 antagonists and the hepcidin mimetic rusfertide.
Talk
Tue Sep 29
8:35am–9:05am
PN-881: Potential Best-In-Class Oral Peptide IL-17 Antagonist
Emerging Drug Targets
Panel
Wed Sep 30
7:30am–8:15am
Challenges in Small Molecule Discovery for Autoimmune Targets
Emerging Drug Targets · with Drug Hunter

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Protagonist Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction